These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1214 related articles for article (PubMed ID: 15663342)

  • 21. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
    Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
    Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Topical immunomodulator against skin cancer. Does the cream replace the knife? (interview by Dr. Judith Neumaier)].
    Hauschild A
    MMW Fortschr Med; 2005 Sep; 147(37):21. PubMed ID: 16193872
    [No Abstract]   [Full Text] [Related]  

  • 23. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
    Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B
    Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infiltrative trichilemmal carcinoma treated with 5% imiquimod cream.
    Jo JH; Ko HC; Jang HS; Kim MB; Oh CK; Kwon KS
    Dermatol Surg; 2005 Aug; 31(8 Pt 1):973-6. PubMed ID: 16042947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alternative to surgery in basal cell carcinoma in the elderly population: imiquimod 5% cream].
    Arias Santiago SA; Ruiz Villaverde R; Burkhardt Pérez P; Naranjo Sintes R
    Rev Esp Geriatr Gerontol; 2009; 44(2):94-7. PubMed ID: 19285364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryoimmunotherapy: superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod.
    MacFarlane DF; El Tal AK
    Arch Dermatol; 2011 Nov; 147(11):1326-7. PubMed ID: 22106125
    [No Abstract]   [Full Text] [Related]  

  • 27. Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.
    Lonergan CL; McNamara EK; Cordoro KM; Greer KE
    Cutis; 2010 Apr; 85(4):199-202. PubMed ID: 20486460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
    Moehrle M; Breuninger H; Schippert W; Häfner HM
    Dermatol Surg; 2010 Mar; 36(3):428-30. PubMed ID: 20402949
    [No Abstract]   [Full Text] [Related]  

  • 29. Do lasers or topicals really work for nonmelanoma skin cancers?
    Brightman L; Warycha M; Anolik R; Geronemus R
    Semin Cutan Med Surg; 2011 Mar; 30(1):14-25. PubMed ID: 21540017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localized pemphigus foliaceus induced by topical imiquimod treatment.
    Lin R; Ladd DJ; Powell DJ; Way BV
    Arch Dermatol; 2004 Jul; 140(7):889-90. PubMed ID: 15262711
    [No Abstract]   [Full Text] [Related]  

  • 31. What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial.
    Tinelli M; Ozolins M; Bath-Hextall F; Williams HC
    BMC Dermatol; 2012 Oct; 12():19. PubMed ID: 23035730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.
    Dirschka T; Schmitz L; Bartha Á
    Eur J Dermatol; 2016 Aug; 26(4):408-9. PubMed ID: 27097553
    [No Abstract]   [Full Text] [Related]  

  • 33. Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.
    Harting M; Vujevich J; Goldberg LH
    Dermatol Surg; 2007 Dec; 33(12):1516-9. PubMed ID: 18076623
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple basal cell carcinomas in xeroderma pigmentosum treated with imiquimod 5% cream.
    Malhotra AK; Gupta S; Khaitan BK; Verma KK
    Pediatr Dermatol; 2008; 25(4):488-91. PubMed ID: 18789101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulation by imiquimod in patients with high-risk primary melanoma.
    Narayan R; Nguyen H; Bentow JJ; Moy L; Lee DK; Greger S; Haskell J; Vanchinathan V; Chang PL; Tsui S; Konishi T; Comin-Anduix B; Dauphine C; Vargas HI; Economou JS; Ribas A; Bruhn KW; Craft N
    J Invest Dermatol; 2012 Jan; 132(1):163-9. PubMed ID: 21850019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New cream to treat skin cancer? [news].
    Mayo Clin Health Lett; 2001 Mar; 19(3):4. PubMed ID: 11242841
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: "Imiquimod 5% cream for the treatment of periocular basal cell carcinoma".
    Pakdel F; Kashkouli MB
    Ophthalmic Plast Reconstr Surg; 2011; 27(4):305; author reply 305-6. PubMed ID: 20966793
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream.
    Hannuksela-Svahn A; Nordal E; Christensen OB
    Acta Derm Venereol; 2000; 80(5):381-2. PubMed ID: 11200841
    [No Abstract]   [Full Text] [Related]  

  • 39. Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma.
    Nouri K; O'Connell C; Rivas MP
    J Drugs Dermatol; 2003 Dec; 2(6):669-73. PubMed ID: 14711149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imiquimod to treat basal cell and squamous cell carcinomas.
    Keller CD
    Am Fam Physician; 2005 Jul; 72(1):41. PubMed ID: 16035682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.